High Expressions of Neuronatin Isoforms in Favorable Neuroblastoma
Authors:
- Mayumi HigashiMHMayumi Higashi
- Tatsuro TajiriTTTatsuro Tajiri
- Yoshiaki KinoshitaYKYoshiaki Kinoshita
- Kyosuke TatsutaKTKyosuke Tatsuta
- Ryota SouzakiRSRyota Souzaki
- Yoshihiko MaeharaYMYoshihiko Maehara
- Sachiyo SuitaSSSachiyo Suita
- Tomoaki TaguchiTTTomoaki Taguchi
- 1 August 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 29 (8) , 551-556
Abstract
Neuroblastoma is a malignant solid tumor of children, which derives from the embryonal sympathoadrenal linage. Clinical cases can vary widely from a favorable to an unfavorable prognosis according to the presence of genetic aberrations, such as MYCN amplification. Our cDNA microarray analysis which compared the gene expressions between favorable and unfavorable neuroblastomas showed a high expression of the neuronatin (Nnat) gene in favorable neuroblastomas. Nnat is highly conserved in mammalian species, and its expression appears in nervous systems from the hindbrain to the peripherals during the prenatal periods. The Nnat mRNA expression, investigated in 63 of neuroblastoma samples by quantitative reverse-transcription polymerase chain reaction, was found to be significantly higher in the favorable prognosis groups than in the unfavorable groups. Nnat is an imprinted gene, and its expression in IMR32 neuroblastoma cell line was up-regulated by treatment with a demethylating agent. High expressions of Nnat isoforms induced in an IMR32 neuroblastoma cell line changed the cell morphology to the extension of the neural processes, which thus indicated the occurrence of cell differentiation. In conclusion, the high expressions of Nnat were found to be associated with good prognoses in neuroblastoma, which might indicate tumor differentiation, and its suppressions in unfavorable tumors are considered to be under epigenetic control.Keywords
This publication has 15 references indexed in Scilit:
- Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastomaJournal of Pediatric Surgery, 2004
- A Systematic Review of Molecular and Biological Tumor Markers in NeuroblastomaClinical Cancer Research, 2004
- Neuroblastoma: biology and molecular and chromosomal pathologyThe Lancet Oncology, 2003
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Evaluation of genetic heterogeneity in neuroblastomaSurgery, 2002
- Cloning of humanneuronatin gene and its localization to chromosome-20q11.2–12: the deduced protein is a novel ‘proteolipid’Brain Research, 1996
- Structure and Organization of the HumanNeuronatinGeneGenomics, 1996
- Segment-Specific Expression of the neuronatin Gene during Early Hindbrain DevelopmentDevelopmental Biology, 1995
- Neuronatin mRNA: alternatively spliced forms of a novel brain-specific mammalian developmental geneBrain Research, 1995
- Molecular Cloning of a Novel mRNA (Neuronatin) That Is Highly Expressed in Neonatal Mammalian BrainBiochemical and Biophysical Research Communications, 1994